{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:20:49Z","timestamp":1771676449623,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The relationship of early catheter-related bloodstream infections (CRBSIs) with perioperative neutropenia and antibiotic prophylaxis is not well established. We sought to evaluate perioperative factors associated with early CRBSIs in newly diagnosed pediatric cancer patients, particularly hematologic indices and antibiotic use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively reviewed national registry records of newly diagnosed pediatric cancer patients with port-a-caths inserted using standardized perioperative protocols where only antibiotic use was not regulated. Thirty-day postoperative CRBSI incidence was correlated with preoperative factors using logistic regression and with postoperative blood counts using linear trend analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 243 patients, 17 CRBSIs (7.0%) occurred at median 14 (range, 8\u201328) postoperative days. Early CRBSIs were significantly associated with cancer type [acute myeloid leukemia and other leukemias (AML\/OLs) vs. solid tumors and lymphomas (STLs): odds ratio (OR), 5.09; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0036; acute lymphoblastic leukemia vs. STL: OR 0.83; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0446] but not preoperative antibiotics, absolute neutrophil counts and white blood cell counts. Thirty-day postoperative absolute neutrophil counts and white blood cell trends differed significantly between patients with acute lymphoblastic leukemia and STLs (OR 0.83, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and between AML\/OLs and STLs (OR 5.09, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.005), with AML\/OL patients having the most protracted neutropenia during this period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Contrary to common belief, low preoperative absolute neutrophil counts and lack of preoperative antibiotics were not associated with higher early CRBSI rates. Instead, AML\/OL patients, particularly those with prolonged neutropenia during the first 30 postoperative days, were at increased risk. Our findings do not support the use of empirical preoperative antibiotics and instead identify prolonged postoperative neutropenia as a major contributing factor for early CRBSI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003315","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T20:15:27Z","timestamp":1633119327000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Postoperative Rather Than Preoperative Neutropenia Is Associated With Early Catheter-related Bloodstream Infections in Newly Diagnosed Pediatric Cancer Patients"],"prefix":"10.1097","volume":"41","author":[{"given":"Wen Qi","family":"Cher","sequence":"first","affiliation":[{"name":"Department of Pediatric Medicine, KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Lee","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Wang","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue-Mei","family":"Cheah","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"York Tien","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, KK Women\u2019s and Children\u2019s Hospital, Singapore"},{"name":"Duke NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ehsan","family":"Saffari","sequence":"additional","affiliation":[{"name":"Centre for Quantitative Medicine, Duke NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Bee","family":"Tan","sequence":"additional","affiliation":[{"name":"Infection Control Unit, Division of Nursing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yin","family":"Chong","sequence":"additional","affiliation":[{"name":"Duke NUS Medical School, Singapore"},{"name":"Infectious Diseases Service, Department of Pediatric Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce C. M.","family":"Lam","sequence":"additional","affiliation":[{"name":"Duke NUS Medical School, Singapore"},{"name":"Haematology Oncology Service, Department of Pediatric Subspecialties, KK Women\u2019s and Children\u2019s Hospital, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos H. P.","family":"Loh","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, KK Women\u2019s and Children\u2019s Hospital, Singapore"},{"name":"Duke NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s10096-012-1652-4","article-title":"Catheter-related infections in pediatric patients with cancer.","volume":"31","author":"Cecinati","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/000313480707301035","article-title":"Complications of implanted central venous catheters in neutropenic children.","volume":"73","author":"Elihu","year":"2007","journal-title":"Am Surg"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","article-title":"Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).","volume":"100","author":"B\u00f6ll","year":"2021","journal-title":"Ann Hematol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/pbc.26245","article-title":"It is time to address ambulatory central venous line infections in pediatric hematology\/oncology patients.","volume":"64","author":"Werner","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/pbc.26053","article-title":"Central line associated blood stream infections in pediatric hematology\/oncology patients with different types of central lines.","volume":"63","author":"Hord","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.26194","article-title":"Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients.","volume":"64","author":"Wong Quiles","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1007\/s00520-020-05379-z","article-title":"Infection at diagnosis-a unique challenge in acute myeloid leukemia treatment in developing world.","volume":"28","author":"Pandian","year":"2020","journal-title":"Support Care Cancer"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"e190979","DOI":"10.1001\/jamanetworkopen.2019.0979","article-title":"Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments.","volume":"2","author":"Caterino","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R9-20250615","first-page":"23","article-title":"Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence.","volume":"28","author":"Adler","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jvir.2015.11.051","article-title":"Routine antibiotic prophylaxis for totally implantable venous access device placement: meta-analysis of 2,154 patients.","volume":"27","author":"Johnson","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"304","DOI":"10.29271\/jcpsp.2020.03.304","article-title":"Prophylactic antibiotics for reducing central line-associated blood stream infection in children with totally implantable venous access devices.","volume":"30","author":"Akbar","year":"2020","journal-title":"J Coll Physicians Surg Pak"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/2278-330X.173179","article-title":"Complications of chemoport in children with cancer: experience of 54,100 catheter days from a tertiary cancer center of Southern India.","volume":"4","author":"Aparna","year":"2015","journal-title":"South Asian J Cancer"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/ped.13289","article-title":"Central line-associated bloodstream infection in childhood malignancy: single-center experience.","volume":"59","author":"Miliaraki","year":"2017","journal-title":"Pediatr Int"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/mco.2016.957","article-title":"Chemotherapy-induced neutropenia among pediatric cancer patients in Egypt: risks and consequences.","volume":"5","author":"Badr","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jvir.2013.11.038","article-title":"Clinical predictors of port infections within the first 30 days of placement","volume":"25","author":"Bamba","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.amjsurg.2018.09.022","article-title":"Perioperative antibiotics should be used for placement of implanted central venous ports: a propensity analysis evaluating risk.","volume":"216","author":"Scaife","year":"2018","journal-title":"Am J Surg"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pbc.26225","article-title":"Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: a cohort study.","volume":"64","author":"Viana Taveira","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/annonc\/mds468","article-title":"Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients.","volume":"24","author":"Chen","year":"2013","journal-title":"Ann Oncol"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jvir.2016.10.007","article-title":"Severe neutropenia at the time of implantable subcutaneous chest port insertion is not a risk factor for port removal at a tertiary pediatric center.","volume":"28","author":"Hoss","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/662376","article-title":"Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.","volume":"32","author":"Kelly","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/annonc\/mdw557","article-title":"Infection-related complications during treatment for childhood acute lymphoblastic leukemia.","volume":"28","author":"Inaba","year":"2017","journal-title":"Ann Oncol"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"e0227772","DOI":"10.1371\/journal.pone.0227772","article-title":"Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.","volume":"15","author":"Baier","year":"2020","journal-title":"PLoS One"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"e27231","DOI":"10.1002\/pbc.27231","article-title":"Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia.","volume":"65","author":"L\u00f8hmann","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"e26254","DOI":"10.1002\/pbc.26254","article-title":"Risk factors for bacteremia and central line\u2013associated blood stream infections in children with acute myelogenous leukemia: a single-institution report.","volume":"64","author":"Rogers","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1015-9584(08)60022-6","article-title":"Port-A-Cath insertions in acute leukaemia and childhood malignancies.","volume":"30","author":"Loh","year":"2007","journal-title":"Asian J Surg"},{"key":"R29-20250615","first-page":"CD003295","article-title":"Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients.","volume":"11","author":"van de Wetering","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-198407000-00001","article-title":"Hickman catheter infections in patients with malignancies.","volume":"63","author":"Press","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1072-7515(98)00096-9","article-title":"Risk factors for early infection of central venous catheters in pediatric patients.","volume":"186","author":"Shaul","year":"1998","journal-title":"J Am Coll Surg"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/MPH.0b013e318290c24f","article-title":"Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention program.","volume":"35","author":"Berrueco","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/MPH.0b013e3182820edd","article-title":"Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases.","volume":"35","author":"Kelly","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jpedsurg.2018.10.024","article-title":"Neutropenia at the time of subcutaneous port insertion may not be a risk factor for early infectious complications in pediatric oncology patients.","volume":"54","author":"VanHouwelingen","year":"2019","journal-title":"J Pediatr Surg"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1017\/ice.2019.224","article-title":"Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: a matched-pair analysis.","volume":"40","author":"T\u00f6lle","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ctrv.2006.03.002","article-title":"Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.","volume":"32","author":"Wittman","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2004.09.106","article-title":"Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.","volume":"22","author":"Sung","year":"2004","journal-title":"J Clin Oncol"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jpc.14506","article-title":"Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.","volume":"56","author":"Chong","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1043454218767885","article-title":"Changes in central line\u2013associated bloodstream infection rates among children with immune compromised conditions: an 11-year review.","volume":"35","author":"Linder","year":"2018","journal-title":"J Pediatr Oncol Nurs"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:01:45Z","timestamp":1750003305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003315","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}